Literature DB >> 12675860

Association of transforming growth factor-beta (TGF-beta) T869C (Leu 10Pro) gene polymorphisms with type 2 diabetic nephropathy in Chinese.

Teresa Yuk Hwa Wong1, Peter Poon, Kai Ming Chow, Cheuk Chun Szeto, Man Kuen Cheung, Philip Kam Tao Li.   

Abstract

INTRODUCTION: Transforming growth factor-beta (TGF-beta) is known to play a pivotal role in the regulation of extracellular matrix (ECM) accumulation. Since diabetic nephropathy (DMN) is characterized by basement membrane thickening and mesangial expansion, control of ECM deposition is believed to be important in the pathogenesis of the disease. Recently, TGF-beta T869C (Leu 10Pro) gene polymorphism has been identified which may be associated with circulating TGF-beta levels.
METHODS: In order to examine the relationship between TGF-beta gene polymorphism with DMN in Chinese, we carried out a case-control study, which recruited 123 Chinese type 2 diabetic patients with an average duration of diabetes for 12 years. A total of 58 patients who developed DMN (micro- or macroalbuminuria, with or without renal impairment) were compared with 65 diabetic patients without DMN despite similar duration of disease (normoalbuminuric and creatinine <120 micromol/L). TGF-beta T869C (Leu 10Pro) gene polymorphism was determined by polymerase chain reaction (PCR).
RESULTS: Both groups of patients had similar baseline characteristics, including blood pressure, diabetic control, and duration of diabetes. Distribution of TGF-beta T869C (Leu 10Pro) genotype among the whole group is confined to Hardy Weinberg equilibrium. The DMN+ group has higher frequency of TGF-beta CC/CT genotypes than the DMN- group [CC, CT, TT = (DMN+) 46, 45, 9 (%) vs. (DMN-) 37, 37, 26 (%), P < 0.05]. C allele frequency is also higher in the DMN+ group than DMN- group (69% vs. 55%, P < 0.05). The adjusted odds ratio for TGF-beta CC/CT vs. TT genotype to develop DMN is 3.8 (3.2 to 4.4). Multivariate logistic regression analysis [hypertension, gender, age, duration of diabetes, hemoglobin (HbA1c), usage of angiotensin-converting enzyme (ACE) inhibitor, and cholesterol level] showed that TGF-beta genotype (P = 0.03) is an independent predictor for type 2 DMN. Among patients with DMN, those with TGF-beta CC/CT genotypes also had worse renal function and increased risk for macroalbuminuria.
CONCLUSION: Our results suggest that TGF-beta T869C (Leu 10Pro) gene polymorphism is associated with DMN in Chinese.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12675860     DOI: 10.1046/j.1523-1755.2003.00919.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  15 in total

1.  Association of Transforming Growth Factor Beta-1 (TGF-β1) Genetic Variation with Type 2 Diabetes and End Stage Renal Disease in Two Large Population Samples from North India.

Authors:  Priyanka Raina; Ruhi Sikka; Ramandeep Kaur; Jasmine Sokhi; Kawaljit Matharoo; Virinder Singh; A J S Bhanwer
Journal:  OMICS       Date:  2015-04-14

2.  Association between the T869C polymorphism of transforming growth factor-beta 1 and diabetic nephropathy: a meta-analysis.

Authors:  Hongxia Jia; Lili Yu; Bin Gao; Qiuhe Ji
Journal:  Endocrine       Date:  2011-07-02       Impact factor: 3.633

3.  Association of Chinese medicine constitution susceptibility to diabetic nephropathy and transforming growth factor-β1 (T869C) gene polymorphism.

Authors:  Xin Mou; Wen-hong Liu; Dan-yang Zhou; Ying-hui Liu; Yong-bin Hu; Guo-ling Ma; Cheng-min Shou; Jia-wei Chen; Jin-xi Zhao
Journal:  Chin J Integr Med       Date:  2011-09-11       Impact factor: 1.978

Review 4.  Transforming growth factor-β1 and diabetic nephropathy.

Authors:  Albert S Chang; Catherine K Hathaway; Oliver Smithies; Masao Kakoki
Journal:  Am J Physiol Renal Physiol       Date:  2015-12-30

5.  Association of polymorphism in the transforming growth factor {beta}1 gene with disease outcome and mortality in rheumatoid arthritis.

Authors:  D L Mattey; N Nixon; P T Dawes; J Kerr
Journal:  Ann Rheum Dis       Date:  2005-02-04       Impact factor: 19.103

6.  Evaluation of circulating Transforming growth factor-beta1, Glypican-3 and Golgi protein-73 mRNAs expression as predictive markers for hepatocellular carcinoma in Egyptian patients.

Authors:  Gehan H Ibrahim; Moushira A Mahmoud; Nagwa M Aly
Journal:  Mol Biol Rep       Date:  2013-11-02       Impact factor: 2.316

7.  Computational disease gene identification: a concert of methods prioritizes type 2 diabetes and obesity candidate genes.

Authors:  Nicki Tiffin; Euan Adie; Frances Turner; Han G Brunner; Marc A van Driel; Martin Oti; Nuria Lopez-Bigas; Christos Ouzounis; Carolina Perez-Iratxeta; Miguel A Andrade-Navarro; Adebowale Adeyemo; Mary Elizabeth Patti; Colin A M Semple; Winston Hide
Journal:  Nucleic Acids Res       Date:  2006-06-06       Impact factor: 16.971

8.  Resequencing of genes for transforming growth factor beta1 (TGFB1) type 1 and 2 receptors (TGFBR1, TGFBR2), and association analysis of variants with diabetic nephropathy.

Authors:  Amy Jayne McKnight; David A Savage; Chris C Patterson; Denise Sadlier; A Peter Maxwell
Journal:  BMC Med Genet       Date:  2007-02-23       Impact factor: 2.103

Review 9.  TGF-beta1 gene polymorphism in association with diabetic retinopathy susceptibility: a systematic review and meta-analysis.

Authors:  Lei Liu; Jinghua Jiao; Yu Wang; Jingyang Wu; Desheng Huang; Weiping Teng; Lei Chen
Journal:  PLoS One       Date:  2014-04-07       Impact factor: 3.240

10.  Common variants of inflammatory cytokine genes are associated with risk of nephropathy in type 2 diabetes among Asian Indians.

Authors:  Tarunveer Singh Ahluwalia; Madhu Khullar; Monica Ahuja; Harbir Singh Kohli; Anil Bhansali; Viswanathan Mohan; Radha Venkatesan; Taranjit Singh Rai; Kamal Sud; Pawan K Singal
Journal:  PLoS One       Date:  2009-04-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.